(Q50959752)

26 March 2018

title

Factors related to current and subsequent psychotropic drug use in an elderly cohort. (English)

1 reference

26 March 2018

2

Seeman T

1 reference

26 March 2018

Lisa Berkman

series ordinal

4

object named as

Berkman L

1 reference

26 March 2018

author name string

Dealberto MJ

series ordinal

1

1 reference

26 March 2018

McAvay GJ

series ordinal

3

1 reference

26 March 2018

publication date

1 March 1997

1 reference

26 March 2018

Journal of Clinical Epidemiology

published in

1 reference

26 March 2018

volume

50

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

357-364

1 reference

26 March 2018

Patterns of Psychotherapeutic Drug Use Among Adults in San Francisco

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Cross-national study of the extent of anti-anxiety-sedative drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Use of benzodiazepines in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychotropic drug utilization patterns in a metropolitan population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychotropic drug use in a Swedish community--the importance of demographic and socioeconomic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Patterns of benzodiazepine use in Great Britain as measured by a general population survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychotropic drug use in a representative community sample: the Upper Bavarian study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Self-reported psychotropic drug use and associated factors in a French community sample

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychotropic drug use in a Swedish community--patterns of individual use during 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Changing patterns of psychotropic drug use in the elderly: a five-year update

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Long-term use of benzodiazepines in a Swedish community: an eight-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Sex differences among recipients of benzodiazepines in Dutch general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Psychotropic drug use in an ambulatory elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Medical and psychosocial factors predictive of psychotropic drug use in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Use of drugs by non-institutionalized urban Finns born in 1904-1923 and the association of drug use with mood and self-rated health

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Benzodiazepine use in older, community-dwelling southern Californians: prevalence and clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Risk factors for falls among elderly persons living in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Depressive symptoms in relation to physical health and functioning in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Symptoms of depression in two communities

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Long-term effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900339-3

7 January 2021

10.1016/S0895-4356(96)00339-3

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018